Skip to main content
. 2015 Oct 22;126(22):2484–2490. doi: 10.1182/blood-2015-04-641100

Figure 3.

Figure 3

Clonal evolution in RUNX1 carriers. Asymptomatic carriers of pathogenic germ line RUNX1 variants develop early-onset clonal hematopoiesis (cumulative risk of 81% by age 50 years). As depicted in the model, this finding provides a rationale for testing the hypothesis that clonal hematopoiesis may provide a biomarker for early detection of disease progression in high-risk families.